Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Open accessThe DOI matches its Crossref record; 216 of the 218 references it cites were found in a registry or an index.
Abstract
Abnormalities of the endosomal–lysosomal network (ELN) are a signature feature of Alzheimer's disease (AD). These include the earliest known cytopathology that is specific to AD and that affects endosomes and induces the progressive failure of lysosomes, each of which are directly linked by distinct mechanisms to neurodegeneration. The origins of ELN dysfunction and β‐amyloidogenesis closely overlap, which reflects their common genetic basis, the established early involvement of endosomes and lysosomes in amyloid precursor protein (APP) processing and clearance, and the pathologic effect of certain APP metabolites on ELN functions. Genes that promote β‐amyloidogenesis in AD (APP, PSEN1/2, and APOE4) have primary effects on ELN function. The importance of primary ELN dysfunction to pathogenesis is underscored by the mutations in more than 35 ELN‐related genes that, thus far, are known to cause familial neurodegenerative diseases even though different pathogenic proteins may be involved. In this article, I discuss growing evidence that implicates AD gene–driven ELN disruptions as not only the antecedent pathobiology that underlies β‐amyloidogenesis but also as the essential partner with APP and its metabolites that drive the development of AD, including tauopathy, synaptic dysfunction, and neurodegeneration. The striking amelioration of diverse deficits in animal AD models by remediating ELN dysfunction further supports a need to integrate APP and ELN relationships, including the role of amyloid‐β, into a broader conceptual framework of how AD arises, progresses, and may be effectively therapeutically targeted.—Nixon, R. A. Amyloid precursor protein and endosomal–lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. FASEB J. 31, 2729–2743 (2017). www.fasebj.org
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In summary, oxidative and/or nitrosative damage to multiple proteins, including synaptic proteins is very likely to contribute to the memory problems and other cognitive deficits, reduced ATP availability in neurons, and decreased clearance of abnormal proteins34, creating a “perfect storm” (or sTORm perhaps!) of detrimental cognitive effects in AD9,34,35,41,42.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“In addition to mTOR activation, insulin resistance can also result in neuronal glucose deficiency, with consequent decreased glucose metabolism, impaired ATP production, and dysfunction and/or death7,42”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“Activated mTORC1 is intimately involved in regulation of protein synthesis, autophagy, mitochondrial function, lipogenesis, ketogenesis, and insulin signaling, and is crucially linked to glucose metabolism, where it becomes activated by growth factors, amino acids, and high cellular energy status41,42 (Fig 2).”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
In the citing paper
“This significant mediator of neuronal death is present in the early stages of AD, and evidence of impaired autophagy is also found in aMCI brain and PCAD brains41–43.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [42]
19 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
2 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992
RetractedIntegrative genomics identifies APOE ε4 effectors in Alzheimer's disease
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A. (2013) · Nature · doi:10.1038/nature12415 · Cited by 171
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
The role of autophagy in neurodegenerative disease
Nixon, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3232 · Cited by 2,059
Self-citationNelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050
CNS synaptogenesis promoted by glia-derived cholesterol
Mauch, D. H., Nägler, K., Schumacher, S., Göritz, C., Müller, E.-C., Otto, A., & Pfrieger, F. W. (2001) · Science · doi:10.1126/science.294.5545.1354 · Cited by 1,711 · cited 1×
“Of particular relevance to AD, lipoprotein receptors mediate glia-derived cholesterol transport within the CNS, which is essential to form and maintain synapses (108).”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588
Self-citationCellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers
Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., & Strittmatter, S. M. (2009) · Nature · doi:10.1038/nature07761 · Cited by 1,560
Lysosomal membrane permeabilization in cell death
Boya, P., & Kroemer, G. (2008) · Oncogene · doi:10.1038/onc.2008.310 · Cited by 1,426
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Lysosomes and autophagy in cell death control
Kroemer, G., & Jäättelä, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1738 · Cited by 1,285
Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells
Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253
Lee, J.-H., Yu, W. H., Kumar, A., Lee, S., Mohan, P. S., Peterhoff, C. M., Wolfe, D. M., Martinez-Vicente, M., Massey, A. C., Sovak, G., et al. (2010) · Cell · doi:10.1016/j.cell.2010.05.008 · Cited by 1,212 · cited 5×
“The resulting deacidification of the lysosomal lumen causes myriad deficits in lysosomal hydrolytic and signaling functions and substrate accumulation (119, 142), which are reversed by selectively reacidifying lysosomes.”
BackgroundInfluentialSelf-citationBoland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Self-citationAMPAR Removal Underlies Aβ-Induced Synaptic Depression and Dendritic Spine Loss
Hsieh, H., Boehm, J., Sato, C., Iwatsubo, T., Tomita, T., Sisodia, S., & Malinow, R. (2006) · Neuron · doi:10.1016/j.neuron.2006.10.035 · Cited by 1,042
Xu, H., & Ren, D. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071649 · Cited by 1,034
Spilman, P., Podlutskaya, N., Hart, M. J., Debnath, J., Gorostiza, O., Bredesen, D., Richardson, A., Strong, R., & Galvan, V. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009979 · Cited by 1,033
Synaptic AMPA receptor plasticity and behavior
Kessels, H. W., & Malinow, R. (2009) · Neuron · doi:10.1016/j.neuron.2009.01.015 · Cited by 993 · cited 1×
“Pathologic Rab5 activation that drives endocytic dysfunction in AD negatively impacts LTP and long-term depression (LTD), 2 aspects of synaptic plasticity that are closely associated with learning and memory (64).”
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967
Self-citationAmyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 932
Molecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881
Napolitano, G., & Ballabio, A. (2016) · Journal of Cell Science · doi:10.1242/jcs.146365 · Cited by 845
Cataldo, A. M., Peterhoff, C. M., Troncoso, J. C., Gomez-Isla, T., Hyman, B. T., & Nixon, R. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64538-5 · Cited by 776
Self-citationAutophagy, amyloidogenesis and Alzheimer disease
Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749
Self-citationRecycling Endosomes Supply AMPA Receptors for LTP
Park, M., Penick, E. C., Edwards, J. G., Kauer, J. A., & Ehlers, M. D. (2004) · Science · doi:10.1126/science.1102026 · Cited by 730
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706
Lysosomal cell death at a glance
Aits, S., & Jäättelä, M. (2013) · Journal of Cell Science · doi:10.1242/jcs.091181 · Cited by 667
Rapamycin alleviates toxicity of different aggregate-prone proteins
Berger, Z., Ravikumar, B., Menzies, F. M., Oroz, L. G., Underwood, B. R., Pangalos, M. N., Schmitt, I., Wullner, U., Evert, B. O., O'Kane, C. J., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddi458 · Cited by 657
Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing
Wang, Y., Martinez-Vicente, M., Krüger, U., Kaushik, S., Wong, E., Mandelkow, E.-M., Cuervo, A. M., & Mandelkow, E. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp367 · Cited by 617
β-Secretase Protein and Activity Are Increased in the Neocortex in Alzheimer Disease
Fukumoto, H. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1381 · Cited by 575
Increased expression of the amyloid precursor β‐secretase in Alzheimer's disease
Holsinger, R. M. D., McLean, C. A., Beyreuther, K., Masters, C. L., & Evin, G. (2002) · Annals of Neurology · doi:10.1002/ana.10208 · Cited by 562
An early age increase in vacuolar pH limits mitochondrial function and lifespan in yeast
Hughes, A. L., & Gottschling, D. E. (2012) · Nature · doi:10.1038/nature11654 · Cited by 559
γ-Secretase: proteasome of the membrane?
Kopan, R., & Ilagan, M. X. G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1406 · Cited by 554
Colacurcio, D. J., & Nixon, R. A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.004 · Cited by 548
Self-citationSalehi, A., Delcroix, J.-D., Belichenko, P. V., Zhan, K., Wu, C., Valletta, J. S., Takimoto-Kimura, R., Kleschevnikov, A. M., Sambamurti, K., Chung, P. P., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.05.022 · Cited by 543 · cited 1×
“NGF trophic support to BFCNs is thus disrupted, which induces atrophy of these neurons and cholinergic deficits inDSmousemodels (21, 92) that can be rescued by raising NGF levels (93).”
Self-citationAPPL Proteins Link Rab5 to Nuclear Signal Transduction via an Endosomal Compartment
Miaczynska, M., Christoforidis, S., Giner, A., Shevchenko, A., Uttenweiler-Joseph, S., Habermann, B., Wilm, M., Parton, R. G., & Zerial, M. (2004) · Cell · doi:10.1016/s0092-8674(04)00117-5 · Cited by 539
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532
Zhang, Z., Song, M., Liu, X., Kang, S. S., Kwon, I.-S., Duong, D. M., Seyfried, N. T., Hu, W. T., Liu, Z., Wang, J.-Z., et al. (2014) · Nature Medicine · doi:10.1038/nm.3700 · Cited by 494
Lee, S., Sato, Y., & Nixon, R. A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6412-10.2011 · Cited by 470
Self-citationInterfering with Apoptosis: Ca 2+ -Binding Protein ALG-2 and Alzheimer's Disease Gene ALG-3
Vito, P., Lacaná, E., & D'Adamio, L. (1996) · Science · doi:10.1126/science.271.5248.521 · Cited by 468
Deleterious Effects of Amyloid β Oligomers Acting as an Extracellular Scaffold for mGluR5
Renner, M., Lacor, P. N., Velasco, P. T., Xu, J., Contractor, A., Klein, W. L., & Triller, A. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.029 · Cited by 468
The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol
Barrett, P. J., Song, Y., Van Horn, W. D., Hustedt, E. J., Schafer, J. M., Hadziselimovic, A., Beel, A. J., & Sanders, C. R. (2012) · Science · doi:10.1126/science.1219988 · Cited by 467
Antiamyloidogenic and Neuroprotective Functions of Cathepsin B: Implications for Alzheimer's Disease
Mueller-Steiner, S., Zhou, Y., Arai, H., Roberson, E. D., Sun, B., Chen, J., Wang, X., Yu, G., Esposito, L., Mucke, L., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.027 · Cited by 465
The Autophagy–Lysosomal Pathway in Neurodegeneration: A TFEB Perspective
Martini-Stoica, H., Xu, Y., Ballabio, A., & Zheng, H. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.02.002 · Cited by 436
Yang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429
Self-citationCataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06142.1997 · Cited by 393
Self-citationPerez-Gonzalez, R., Gauthier, S. A., Kumar, A., & Levy, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.404467 · Cited by 385
Sun, L., Zhou, R., Yang, G., & Shi, Y. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618657114 · Cited by 382
Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., & Nixon, R. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90324-0 · Cited by 379
Self-citationSelective clearance of aberrant tau proteins and rescue of neurotoxicity by transcription factor EB
Polito, V. A., Li, H., Martini‐Stoica, H., Wang, B., Yang, L., Xu, Y., Swartzlander, D. B., Palmieri, M., di Ronza, A., Lee, V. M., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303671 · Cited by 368
Holtzman, D. M., Li, Y., Parada, L. F., Kinsman, S., Chen, C.-K., Valletta, J. S., Zhou, J., Long, J. B., & Mobley, W. C. (1992) · Neuron · doi:10.1016/0896-6273(92)90184-f · Cited by 365
Cathepsin D targeted by acid sphingomyelinase-derived ceramide
Heinrich, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5252 · Cited by 365
Neurodegenerative lysosomal disorders: A continuum from development to late age
Nixon, R. A., Yang, D.-S., & Lee, J.-H. (2008) · Autophagy · doi:10.4161/auto.6259 · Cited by 362
Self-citationCataldo, A., Hamilton, D., Barnett, J., Paskevich, P., & Nixon, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-01-00186.1996 · Cited by 359
Self-citationLee, J.-H., McBrayer, M. K., Wolfe, D. M., Haslett, L. J., Kumar, A., Sato, Y., Lie, P. P. Y., Mohan, P., Coffey, E. E., Kompella, U., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.050 · Cited by 358 · cited 3×
“In addition, both presenilins have secretase-independent roles as uncleaved polypeptides (119, 142, 164, 165).”
Self-citationBordi, M., Berg, M. J., Mohan, P. S., Peterhoff, C. M., Alldred, M. J., Che, S., Ginsberg, S. D., & Nixon, R. A. (2016) · Autophagy · doi:10.1080/15548627.2016.1239003 · Cited by 353 · cited 3×
“Endocytosis and autophagy, major pathways of APP processing and Ab generation, are both up-regulated in AD (22, 138, 190).”
BackgroundSelf-citationYang, T., Li, S., Xu, H., Walsh, D. M., & Selkoe, D. J. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1698-16.2016 · Cited by 347
Depletion of GGA3 Stabilizes BACE and Enhances β-Secretase Activity
Tesco, G., Koh, Y. H., Kang, E. L., Cameron, A. N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.-H., Zhong, Z., Shen, Y., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.012 · Cited by 337
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Schmitz, T. W., Nathan Spreng, R., Initiative, T. A. D. N., Weiner, M. W., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., Toga, A. W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13249 · Cited by 335
Neuronal loss and brain atrophy in mice lacking cathepsins B and L
Felbor, U., Kessler, B., Mothes, W., Goebel, H. H., Ploegh, H. L., Bronson, R. T., & Olsen, B. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112632299 · Cited by 334
Kumar-Singh, S., Theuns, J., Van Broeck, B., Pirici, D., Vennekens, K., Corsmit, E., Cruts, M., Dermaut, B., Wang, R., & Van Broeckhoven, C. (2006) · Human Mutation · doi:10.1002/humu.20336 · Cited by 323
Pasternak, S. H., Bagshaw, R. D., Guiral, M., Zhang, S., Ackerley, C. A., Pak, B. J., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304009200 · Cited by 316
Alzheimer's disease: synapses gone cold
Koffie, R. M., Hyman, B. T., & Spires-Jones, T. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-63 · Cited by 308
McConlogue, L., Buttini, M., Anderson, J. P., Brigham, E. F., Chen, K. S., Freedman, S. B., Games, D., Johnson-Wood, K., Lee, M., Zeller, M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611687200 · Cited by 300
Sannerud, R., Esselens, C., Ejsmont, P., Mattera, R., Rochin, L., Tharkeshwar, A. K., De Baets, G., De Wever, V., Habets, R., Baert, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.020 · Cited by 299
Jiang, Y., Mullaney, K. A., Peterhoff, C. M., Che, S., Schmidt, S. D., Boyer-Boiteau, A., Ginsberg, S. D., Cataldo, A. M., Mathews, P. M., & Nixon, R. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908953107 · Cited by 292
Self-citationSurvival of Adult Basal Forebrain Cholinergic Neurons After Loss of Target Neurons
Sofroniew, M. V., Galletly, N. P., Isacson, O., & Svendsen, C. N. (1990) · Science · doi:10.1126/science.1688664 · Cited by 284
Hamano, T., Gendron, T. F., Causevic, E., Yen, S., Lin, W., Isidoro, C., DeTure, M., & Ko, L. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06084.x · Cited by 283
Grothe, M., Heinsen, H., & Teipel, S. J. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.019 · Cited by 281
Mufson, E. J., Bothwell, M., & Kordower, J. H. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90124-6 · Cited by 279
Loss of Bin1 Promotes the Propagation of Tau Pathology
Calafate, S., Flavin, W., Verstreken, P., & Moechars, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.063 · Cited by 265
Endolysosomes Are the Principal Intracellular Sites of Acid Hydrolase Activity
Bright, N. A., Davis, L. J., & Luzio, J. P. (2016) · Current Biology · doi:10.1016/j.cub.2016.06.046 · Cited by 263
Impact of lysosome status on extracellular vesicle content and release
Eitan, E., Suire, C., Zhang, S., & Mattson, M. P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.001 · Cited by 255
Muhammad, A., Flores, I., Zhang, H., Yu, R., Staniszewski, A., Planel, E., Herman, M., Ho, L., Kreber, R., Honig, L. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802545105 · Cited by 248 · cited 2×
“mutation to Parkinson’s disease, misfunctions in AD, as evidenced by early deficiency of its Vps35 and -36 components (11, 12).”
BackgroundGinsberg, S. D., Alldred, M. J., Counts, S. E., Cataldo, A. M., Neve, R. L., Jiang, Y., Wuu, J., Chao, M. V., Mufson, E. J., Nixon, R. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.030 · Cited by 243
Self-citationAutophagy in neurons: a review.
Larsen, K. E., & Sulzer, D. L. (2002) · PubMed · doi:10.14670/hh-17.897 · Cited by 241
Missotten, M., Nichols, A., Rieger, K., & Sadoul, R. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400456 · Cited by 239
Vito, P., Pellegrini, L., Guiet, C., & D'Adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1533 · Cited by 234
Tian, Y., Chang, J. C., Fan, E. Y., Flajolet, M., & Greengard, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315110110 · Cited by 233 · cited 1×
“via specialized autophagic routes (153, 154), and lysosomal metabolism of bCTF is highly vulnerable to the inhibition of cysteine proteases (155) and by crosstalk between endoplasmic reticulum-associated degradation and ubiquitinindependent lysosomal degradation (156); exosomes are another elimination route for bCTF f…”
Sun, B., Zhou, Y., Halabisky, B., Lo, I., Cho, S.-H., Mueller-Steiner, S., Devidze, N., Wang, X., Grubb, A., & Gan, L. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.001 · Cited by 231
GGA Proteins Mediate the Recycling Pathway of Memapsin 2 (BACE)
He, X., Li, F., Chang, W.-P., & Tang, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411296200 · Cited by 228
Granholm, A.-C. E., Sanders, L. A., & Crnic, L. S. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7289 · Cited by 228
Retromer in Alzheimer disease, Parkinson disease and other neurological disorders
Small, S. A., & Petsko, G. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3896 · Cited by 227
Lifespan Extension by Methionine Restriction Requires Autophagy-Dependent Vacuolar Acidification
Ruckenstuhl, C., Netzberger, C., Entfellner, I., Carmona-Gutierrez, D., Kickenweiz, T., Stekovic, S., Gleixner, C., Schmid, C., Klug, L., Sorgo, A. G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004347 · Cited by 224
Tian, Y., Bustos, V., Flajolet, M., & Greengard, P. (2011) · The FASEB Journal · doi:10.1096/fj.10-175158 · Cited by 224
De Jonghe, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.16.1665 · Cited by 223
Lysosomal system pathways: Genes to neurodegeneration in Alzheimer's disease
Nixon, R. A., & Cataldo, A. M. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s331 · Cited by 222
Self-citationBrown, T. C., Tran, I. C., Backos, D. S., & Esteban, J. A. (2005) · Neuron · doi:10.1016/j.neuron.2004.12.023 · Cited by 222
Lauritzen, I., Pardossi-Piquard, R., Bourgeois, A., Pagnotta, S., Biferi, M.-G., Barkats, M., Lacor, P., Klein, W., Bauer, C., & Checler, F. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1577-6 · Cited by 219 · cited 1×
“neuronal death in AD are not clear but are likely to include intralysosomal accumulationof not onlyAb (16, 26, 75, 150, 206, 213) but also of bCTF (75, 76), other APP fragments, and membrane-destabilizing oxidized lipids and proteins.”
BackgroundLysosomal cell death mechanisms in aging
Gómez-Sintes, R., Ledesma, M. D., & Boya, P. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.02.009 · Cited by 216
Kim, S., Sato, Y., Mohan, P. S., Peterhoff, C., Pensalfini, A., Rigoglioso, A., Jiang, Y., & Nixon, R. A. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.97 · Cited by 212
Self-citationThe molecular machinery for lysosome biogenesis*
Mullins, C., & Bonifacino, J. S. (2001) · BioEssays · doi:10.1002/bies.1048 · Cited by 208
Lauritzen, I., Pardossi-Piquard, R., Bauer, C., Brigham, E., Abraham, J.-D., Ranaldi, S., Fraser, P., St-George-Hyslop, P., Le Thuc, O., Espin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2775-12.2012 · Cited by 201 · cited 1×
“neuronal death in AD are not clear but are likely to include intralysosomal accumulationof not onlyAb (16, 26, 75, 150, 206, 213) but also of bCTF (75, 76), other APP fragments, and membrane-destabilizing oxidized lipids and proteins.”
BackgroundEckman, C. B., & Eckman, E. A. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051101 · Cited by 200
Goveia, J., Stapor, P., & Carmeliet, P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404156 · Cited by 200
Maloney, J. A., Bainbridge, T., Gustafson, A., Zhang, S., Kyauk, R., Steiner, P., van der Brug, M., Liu, Y., Ernst, J. A., Watts, R. J., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.589069 · Cited by 197
Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., et al. (2002) · Journal of Comparative Neurology · doi:10.1002/cne.10122 · Cited by 197
P. Imbimbo, B., & A.M. Giardina, G. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795860942 · Cited by 194
Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway
Das, U., Wang, L., Ganguly, A., Saikia, J. M., Wagner, S. L., Koo, E. H., & Roy, S. (2016) · Nature Neuroscience · doi:10.1038/nn.4188 · Cited by 192
Brendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., Mathis, C. A., Bales, K. R., Paul, S. M., Hyman, B. T., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23269 · Cited by 190
Down Syndrome Fibroblast Model of Alzheimer-Related Endosome Pathology
Cataldo, A. M., Mathews, P. M., Boiteau, A. B., Hassinger, L. C., Peterhoff, C. M., Jiang, Y., Mullaney, K., Neve, R. L., Gruenberg, J., & Nixon, R. A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071053 · Cited by 186
Self-citationThe biochemistry of neuronal necrosis: rogue biology?
Syntichaki, P., & Tavernarakis, N. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1174 · Cited by 183
Xu, W., Weissmiller, A. M., White, J. A., Fang, F., Wang, X., Wu, Y., Pearn, M. L., Zhao, X., Sawa, M., Chen, S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82409 · Cited by 182
The neuropathogenic contributions of lysosomal dysfunction
Bahr, B. A., & Bendiske, J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01192.x · Cited by 180
Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease
Gamba, P., Testa, G., Gargiulo, S., Staurenghi, E., Poli, G., & Leonarduzzi, G. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00119 · Cited by 180
Ji, Z.-S., Miranda, R. D., Newhouse, Y. M., Weisgraber, K. H., Huang, Y., & Mahley, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112109200 · Cited by 177
Beel, A. J., Mobley, C. K., Kim, H. J., Tian, F., Hadziselimovic, A., Jap, B., Prestegard, J. H., & Sanders, C. R. (2008) · Biochemistry · doi:10.1021/bi800993c · Cited by 174
Endocytosis, Signaling, and Beyond
Di Fiore, P. P., & von Zastrow, M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016865 · Cited by 172
Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease
Huang, Y. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.04.004 · Cited by 170
Brain Disorders Due to Lysosomal Dysfunction
Fraldi, A., Klein, A. D., Medina, D. L., & Settembre, C. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014031 · Cited by 170
Devi, L., & Ohno, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.04.031 · Cited by 169
Neuronal Signaling through Endocytosis
Cosker, K. E., & Segal, R. A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a020669 · Cited by 168
Beel, A. J., Sakakura, M., Barrett, P. J., & Sanders, C. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.008 · Cited by 167
Signal processing by the endosomal system
Villaseñor, R., Kalaidzidis, Y., & Zerial, M. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.02.002 · Cited by 167
Neuronal Apoptosis and Autophagy Cross Talk in Aging PS/APP Mice, a Model of Alzheimer's Disease
Yang, D.-S., Kumar, A., Stavrides, P., Peterson, J., Peterhoff, C. M., Pawlik, M., Levy, E., Cataldo, A. M., & Nixon, R. A. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071176 · Cited by 164
Self-citationNegative regulation of PI 3‐kinase by Ruk, a novel adaptor protein
Gout, I. T., Middleton, G., Adu, J., Ninkina, N. N., Дробот, Л. Б., Filonenko, V., Matsuka, G., Davies, A. M., Waterfield, M. D., & Buchman, V. L. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4015 · Cited by 160
Autophagy, a guardian against neurodegeneration
García-Arencibia, M., Hochfeld, W. E., Toh, P. P. C., & Rubinsztein, D. C. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2010.02.008 · Cited by 158
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158 · cited 2×
“Relative toApoE3/2,ApoE4disproportionatelydisruptsprocesses ranging from lipoprotein trafficking to synaptic plasticity and neurite outgrowth (104), some ofwhich are likely also related to ApoE4 effects in the promotion of endosomopathy.”
BackgroundCataldo, A. M., Peterhoff, C. M., Schmidt, S. D., Terio, N. B., Duff, K., Beard, M., Mathews, P. M., & Nixon, R. A. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.8.821 · Cited by 157
Self-citationNistor, M., Don, M., Parekh, M., Sarsoza, F. M., Goodus, M. T., López, G., Kawas, C. H., Leverenz, J. B., Doran, E. W., Lott, I. T., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.023 · Cited by 157
Lipid sorting and multivesicular endosome biogenesis
Bissig, C., & Gruenberg, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016816 · Cited by 151
A Caspase Cleaved Form of Tau Is Preferentially Degraded through the Autophagy Pathway
Dolan, P. J., & Johnson, G. V. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.110940 · Cited by 148
Schnöder, L., Hao, W., Qin, Y., Liu, S., Tomic, I., Liu, X., Fassbender, K., & Liu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695916 · Cited by 148
Lysosomal Dysfunction Promotes Cleavage and Neurotoxicity of Tau In Vivo
Khurana, V., Elson-Schwab, I., Fulga, T. A., Sharp, K. A., Loewen, C. A., Mulkearns, E., Tyynelä, J., Scherzer, C. R., & Feany, M. B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001026 · Cited by 147
Bohdanowicz, M., Balkin, D. M., De Camilli, P., & Grinstein, S. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0489 · Cited by 146
Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease.
Basurto-Islas, G., Grundke-Iqbal, I., Tung, Y. C., Liu, F., & Iqbal, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446070 · Cited by 144
Tamayev, R., Matsuda, S., Arancio, O., & D'Adamio, L. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100195 · Cited by 142
Merkulova, M., Păunescu, T. G., Azroyan, A., Marshansky, V., Breton, S., & Brown, D. (2015) · Scientific Reports · doi:10.1038/srep14827 · Cited by 141
Pathophysiology of neuropathic lysosomal storage disorders
Bellettato, C. M., & Scarpa, M. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9075-9 · Cited by 141
Impaired recycling of apolipoprotein E4 is associated with intracellular cholesterol accumulation
Heeren, J., Grewal, T., Laatsch, A., Becker, N., Rinninger, F., Rye, K.-A., & Beisiegel, U. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409324200 · Cited by 139
Lin, D. C., Quevedo, C., Brewer, N. E., Bell, A., Testa, J. R., Grimes, M. L., Miller, F. D., & Kaplan, D. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00228-06 · Cited by 137
Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy
Ohmi, K., Kudo, L. C., Ryazantsev, S., Zhao, H.-Z., Karsten, S. L., & Neufeld, E. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903223106 · Cited by 132
McPhie, D. L., Coopersmith, R., Hines-Peralta, A., Chen, Y., Ivins, K. J., Manly, S. P., Kozlowski, M. R., Neve, K. A., & Neve, R. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-17-06914.2003 · Cited by 130
Reactivity of Apolipoprotein E4 and Amyloid β Peptide
Ji, Z.-S., Müllendorff, K., Cheng, I. H., Miranda, R. D., Huang, Y., & Mahley, R. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506646200 · Cited by 127
APPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor
Ryu, J., Galan, A. K., Xin, X., Dong, F., Abdul-Ghani, M. A., Zhou, L., Wang, C., Li, C., Holmes, B. M., Sloane, L. B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.006 · Cited by 127
Structure of the APPL1 BAR-PH domain and characterization of its interaction with Rab5
Zhu, G., Chen, J., Liu, J., Brunzelle, J. S., Huang, B., Wakeham, N., Terzyan, S., Li, X., Rao, Z., Li, G., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601771 · Cited by 127
Lysosomal adaptation: how the lysosome responds to external cues
Settembre, C., & Ballabio, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016907 · Cited by 126
Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits
Frautschy, S. A., Yang, F., Calderón, L., & Cole, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02073-x · Cited by 125
Xue, X., Wang, L.-R., Sato, Y., Jiang, Y., Berg, M., Yang, D.-S., Nixon, R. A., & Liang, X.-J. (2014) · Nano Letters · doi:10.1021/nl501839q · Cited by 125
Self-citationFlorez-McClure, M. L., Hohsfield, L. A., Fonte, G., Bealor, M. T., & Link, C. D. (2007) · Autophagy · doi:10.4161/auto.4776 · Cited by 124
Simón, A., Schiapparelli, L., Colocho, P. E. S., Cuadrado‐Tejedor, M., Escribano, L., de Maturana, R. L., Río, J. D., Pérez‐Mediavilla, A., & Frechilla, D. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.11.005 · Cited by 123
Chen, B., Borinstein, S. C., Gillis, J., Sykes, V. W., & Bogler, O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908994199 · Cited by 123
Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways
Duggan, S. P., & McCarthy, J. V. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.10.006 · Cited by 119
A lysosome-centered view of nutrient homeostasis
Mony, V. K., Benjamin, S., & O'Rourke, E. J. (2016) · Autophagy · doi:10.1080/15548627.2016.1147671 · Cited by 119
Alzheimer's β-Secretase (BACE1) Regulates the cAMP/PKA/CREB Pathway Independently of β-Amyloid
Chen, Y., Huang, X., Zhang, Y.-W., Rockenstein, E., Bu, G., Golde, T. E., Masliah, E., & Xu, H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0757-12.2012 · Cited by 117
Yang, D.-S., Stavrides, P., Saito, M., Kumar, A., Rodriguez-Navarro, J. A., Pawlik, M., Huo, C., Walkley, S. U., Saito, M., Cuervo, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu278 · Cited by 114
Self-citationLiang, B., Duan, B.-Y., Zhou, X.-P., Gong, J.-X., & Luo, Z.-G. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.117960 · Cited by 110
He, X., Cooley, K., Chung, C. H. Y., Dashti, N., & Tang, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3993-06.2007 · Cited by 107
Woodruff, G., Reyna, S. M., Dunlap, M., Van Der Kant, R., Callender, J. A., Young, J. E., Roberts, E. A., & Goldstein, L. S. B. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.034 · Cited by 105
Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models
Butler, D., Hwang, J., Estick, C., Nishiyama, A., Kumar, S. S., Baveghems, C. L., Young-Oxendine, H. B., Wisniewski, M. L., Charalambides, A., & Bahr, B. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020501 · Cited by 102
Proteomic identification of sorting nexin 6 as a negative regulator of BACE1‐mediated APP processing
Okada, H., Zhang, W., Peterhoff, C., Hwang, J. C., Nixon, R. A., Ryu, S. H., & Kim, T. (2010) · The FASEB Journal · doi:10.1096/fj.09-146357 · Cited by 102
Self-citationYang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D. W., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Autophagy · doi:10.4161/auto.7.7.15596 · Cited by 101
Self-citationBelinson, H., Lev, D., Masliah, E., & Michaelson, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5633-07.2008 · Cited by 101
Ivy, G. O., Kanai, S., Ohta, M., Smith, G., Sato, Y., Kobayashi, M., & Kitani, K. (1990) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-5339-1_3 · Cited by 101
Ryazantsev, S., Yu, W.-H., Zhao, H., Neufeld, E. F., & Ohmi, K. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.11.006 · Cited by 100
Rao, M. V., McBrayer, M. K., Campbell, J., Kumar, A., Hashim, A., Sershen, H., Stavrides, P. H., Ohno, M., Hutton, M., & Nixon, R. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1132-14.2014 · Cited by 99
Self-citationCalcium signaling in membrane repair
Cheng, X., Zhang, X., Yu, L., & Xu, H. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.10.031 · Cited by 97
BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice2
Nishitomi, K., Sakaguchi, G., Horikoshi, Y., Gray, A. J., Maeda, M., Hirata‐Fukae, C., Becker, A. G., Hosono, M., Sakaguchi, I., Minami, S. S., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04178.x · Cited by 97
The Role of Autophagy in Age-Related Neurodegeneration
McCray, B. A., & Taylor, J. P. (2008) · Neurosignals · doi:10.1159/000109761 · Cited by 90
Kalaidzidis, I., Miaczynska, M., Brewińska-Olchowik, M., Hupalowska, A., Ferguson, C., Parton, R. G., Kalaidzidis, Y., & Zerial, M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201311117 · Cited by 90
Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime
McBrayer, M., & Nixon, R. A. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130201 · Cited by 89
Self-citationSiman, R., Mistretta, S., Durkin, J. T., Savage, M. J., Loh, T., Trusko, S., & Scott, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85462-5 · Cited by 88
Neurotrophin signaling endosomes: biogenesis, regulation, and functions
Yamashita, N., & Kuruvilla, R. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2016.06.004 · Cited by 83
Review: Autophagy and neurodegeneration: survival at a cost?
Cherra III, S. J., Dagda, R. K., & Chu, C. T. (2010) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01062.x · Cited by 81
Tamayev, R., & D’Adamio, L. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-19 · Cited by 81
The RAS Effector RIN1 Modulates the Formation of Aversive Memories
Dhaka, A., Costa, R. M., Hu, H., Irvin, D. K., Patel, A., Kornblum, H. I., Silva, A. J., O'Dell, T. J., & Colicelli, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-03-00748.2003 · Cited by 75
Yeates, E. F. A., & Tesco, G. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.718023 · Cited by 70
Xu, W., Fitzgerald, S., Nixon, R. A., Levy, E., & Wilson, D. A. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.008 · Cited by 69
Self-citationβ-Secretase: its biology as a therapeutic target in diseases
Wang, H., Li, R., & Shen, Y. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.008 · Cited by 69
Rab5 Mediates an Amyloid Precursor Protein Signaling Pathway That Leads to Apoptosis
Laifenfeld, D., Patzek, L. J., McPhie, D. L., Chen, Y., Levites, Y., Cataldo, A. M., & Neve, R. L. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4599-06.2007 · Cited by 68
Lysosomes in programmed cell death pathways: from initiators to amplifiers
Kavčič, N., Pegan, K., & Turk, B. (2017) · Biological Chemistry · doi:10.1515/hsz-2016-0252 · Cited by 66
Frautschy, S. A., Horn, D. L., Sigel, J. J., Harris-White, M. E., Mendoza, J. J., Yang, F., Saido, T. C., & Cole, G. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08311.1998 · Cited by 65
Can ‘calpain-cathepsin hypothesis’ explain Alzheimer neuronal death?
Yamashima, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.008 · Cited by 65
Muth, K., Schönmeyer, R., Matura, S., Haenschel, C., Schröder, J., & Pantel, J. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.026 · Cited by 63
The role of CHMP2B in frontotemporal dementia
Urwin, H., Ghazi-Noori, S., Collinge, J., & Isaacs, A. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370208 · Cited by 62
On the role of v-ATPase V0a1–dependent degradation in Alzheimer Disease
Williamson, W. R., & Hiesinger, P. R. (2010) · Communicative & Integrative Biology · doi:10.4161/cib.3.6.13364 · Cited by 57
Kim, H., Kim, E., Kim, N., Chang, K., Choi, Y., Ahn, K., Lee, J., Kim, S., Park, C. H., & Suh, Y. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.10845 · Cited by 57
Jayne, T., Newman, M., Verdile, G., Sutherland, G. T., Münch, G. W., Musgrave, I., Nik, S. H. M., & Lardelli, M. T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151186 · Cited by 56
Thomas, R. S., Henson, A., Gerrish, A., Jones, L., Williams, J., & Kidd, E. J. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0288-1 · Cited by 55
APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant
Tamayev, R., Matsuda, S., Giliberto, L., Arancio, O., & D'adamio, L. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.161 · Cited by 54
Novotny, R., Langer, F., Mahler, J., Skodras, A., Vlachos, A., Wegenast-Braun, B. M., Kaeser, S. A., Neher, J. J., Eisele, Y. S., Pietrowski, M. J., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0258-16.2016 · Cited by 54
Nicastrin is a resident lysosomal membrane protein
Bagshaw, R. D., Pasternak, S., Mahuran, D. J., & Callahan, J. W. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02865-6 · Cited by 50
Enhancement of BACE1 Activity by p25/Cdk5-Mediated Phosphorylation in Alzheimer’s Disease
Song, W.-J., Son, M.-Y., Lee, H.-W., Seo, H., Kim, J. H., & Chung, S.-H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136950 · Cited by 50
Cossec, J., Marquer, C., Panchal, M., Lazar, A. N., Duyckaerts, C. J., & Potier, M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.010 · Cited by 49
Apolipoprotein E genotype and neurological disease onset in Niemann–Pick disease, type C1
Fu, R., Yanjanin, N. M., Elrick, M. J., Ware, C. M., Lieberman, A. P., & Porter, F. D. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35395 · Cited by 48
Fu, X., Yang, Y., Xu, C., Niu, Y., Chen, T., Zhou, Q., & Liu, J.-J. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0308 · Cited by 48
Choi, S. H., Park, C. H., Koo, J. W., Seo, J.-H., Kim, H.-S., Jeong, S.-J., Lee, J.-H., Kim, S. S., & Suh, Y.-H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0859fje · Cited by 47
Cai, Y., Zhang, X.-M., Macklin, L. N., Cai, H., Luo, X.-G., Oddo, S., LaFerla, F. M., Struble, R. G., Rose, G. M., Patrylo, P. R., et al. (2012) · Neurotoxicity Research · doi:10.1007/s12640-011-9256-9 · Cited by 45
Majumdar, D., Nebhan, C. A., Hu, L., Anderson, B., & Webb, D. J. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.01.003 · Cited by 45
Ling, D., Magallanes, M., & Salvaterra, P. M. (2014) · ASN Neuro · doi:10.1042/an20130044 · Cited by 44
The Role of Brain Cholesterol and its Oxidized Products in Alzheimer's Disease
Maria Giudetti, A., Romano, A., Michele Lavecchia, A., & Gaetani, S. (2016) · Current Alzheimer Research · doi:10.2174/1567205012666150921103426 · Cited by 41
Bustamante, H. A., Rivera-Dictter, A., Cavieres, V. A., Muñoz, V. C., González, A., Lin, Y., Mardones, G. A., & Burgos, P. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083096 · Cited by 40
Nguyen, K., & Rabenstein, D. L. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5b12235 · Cited by 40
Yang, D.-S., Stavrides, P. H., Kumar, A. R., Jiang, Y., Mohan, P. S., Ohno, M., Dobrenis, K., Davidson, C. D., Saito, M., Pawlik, M., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx001 · Cited by 40
Self-citationThe convergence of endosomal and autophagosomal pathways: Implications for APP-CTF degradation
Tian, Y., Chang, J. C., Greengard, P., & Flajolet, M. (2014) · Autophagy · doi:10.4161/auto.27802 · Cited by 39
Yoon, S. Y., Choi, J. E., Yoon, J. H., Huh, J.-W., & Kim, D. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.12.013 · Cited by 39
LeBlanc, A. C., & Goodyer, C. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721832.x · Cited by 39
Natunen, T., Takalo, M., Kemppainen, S., Leskelä, S., Marttinen, M., Kurkinen, K. M. A., Pursiheimo, J., Sarajärvi, T., Viswanathan, J., Gabbouj, S., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.005 · Cited by 38
Research works printed but not linked: 1
- 10.1111/j.1365-2990.2010.01062.x · doi:10.1111/j.1365-2990.2010.01062.x · Paper page
Cited by
Knopman, D. S., Amieva, H., Petersen, R. C., Chételat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00269-y · Cited by 2,606
Self-citationOxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
The Amyloid-β Pathway in Alzheimer’s Disease
Hampel, H., Hardy, J., Blennow, K., Chen, C., Perry, G., Kim, S. H., Villemagne, V. L., Aisen, P., Vendruscolo, M., Iwatsubo, T., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01249-0 · Cited by 1,952
“Alternatively, APP can enter the lysosomal pathway and undergo proteolytic degradation [105].”
BackgroundInfluentialLysosomes as dynamic regulators of cell and organismal homeostasis
Ballabio, A., & Bonifacino, J. S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0185-4 · Cited by 1,469
Mizushima, N., & Levine, B. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2022774 · Cited by 1,140
Metadata
- Authors
- Nixon, R. A.
- Affiliations
- Nathan Kline Institute for Psychiatric Research (US)
- Corresponding author
- Nixon, Ralph A.
- ORCID
- Nixon, Ralph A.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2017-06-14
- Volume
- 31
- Issue
- 7
- Pages
- 2729-2743
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- PMC
- PMC6137496
- OpenAlex
- W2728546490
- Cited by
- 400
- References
- 218
- Citations by year
- 2026: 39 · 2025: 55 · 2024: 44 · 2023: 36 · 2022: 50 · 2021: 55 · 2020: 55 · 2019: 34 · 2018: 25 · 2017: 7
- FWCI
- 4.06
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The FASEB Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- National Institutes of Health
- National Institute on Aging
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- Alzheimer's disease, amyloid precursor protein, lysosomal dysfunction, endosomes, APP processing, presenilin 1, presenilin 2, APOE ε4, tauopathy, synaptic dysfunction, neurodegeneration, familial neurodegenerative disease, animal models of Alzheimer's disease, therapeutic target
- MeSH terms
- Alzheimer Disease, Gene Expression Regulation, Humans, Lysosomes, Endosomes, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.